The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients
- 1 October 1981
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 11 (5) , 389-395
- https://doi.org/10.1111/j.1365-2362.1981.tb02001.x
Abstract
The effect of the converting enzyme inhibitor captopril on the activity of the sympathetic nervous system during basal conditions and following graded physical exercise in patients with essential hypertension was explored. Seven males and 2 females, aged 36-59 yr, were hospitalized under metabolic ward conditions and treated for 7 days with captopril given orally in increasing dosages, the final dose being 600 mg daily. The patients were subjected to an individual, graded submaximal work test (bicycling) for 20 min before medication and then again in an identical manner during medication with 600 mg captopril. Blood samples were drawn before exercise and then after 10 and 20 min of work for the determination of plasma angiotensin II (PA II), plasma aldosterone (PAC), plasma renin activity (PRA), plasma noradrenaline [norepinephrine] (PNA) and plasma adrenaline [epinephrine] (PA). Before medication blood pressure (mmHg) was 195/133 immediately before exercise, 230/129 after 10 min of moderate exercise and 263/105 following 20 min of nearly maximal work. During treatment with captopril the respective blood pressure values were 154/110, 200/100 and 245/98. Captopril had no significant effect on the changes in heart rate following physical exercise. PA II and PAC were substantially reduced and PRA considerably increased by captopril. PA II, PAC and PRA increased in response to exercise both before and following captopril. The exercise stimulated increase in PNA and PA was almost identical before and during captopril. Thus, captopril had no major effect on the activity of the sympathetic nervous system in patients with essential hypertension, neither during basic conditions nor during heavy physical exercise despite a profound decrease in PA II.Keywords
This publication has 20 references indexed in Scilit:
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- The Effect of the Converting Enzyme Inhibitor SQ 20.881 on Kinins, Renin‐Angiotensin‐Aldosterone and Catecholamines in Relation to Blood Pressure in Hypertensive PatientsActa Medica Scandinavica, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Measurement of angiotensin II in human plasma: Technical modifications and practical experienceClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Design of exercise test, with special reference to heart patients.Heart, 1976
- The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugsProgress in Cardiovascular Diseases, 1974
- Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulationEuropean Journal of Pharmacology, 1972
- Centrally Mediated Vasopressor Effect of Angiotensin II in ManJapanese Heart Journal, 1969
- Interference of Phenoxybenzamine and Guanethidine with the Vasoconstrictor Responses of Noradrenaline and Angiotensin II in the HandActa Pharmacologica et Toxicologica, 1967